Skip to main content

Table 1 Demographic and clinical characteristics of patients with juvenile idiopathic arthritis (N = 51) and controls (N = 52).

From: Homocysteine and lipid profile in children with Juvenile Idiopathic Arthritis

 

Patients

Controls

Epidemiological Characteristics

n

(%)

n

(%)

Gender

    

   Female

37

(72.6)

42

(80.1)

   Male

14

(27.4)

10

(19.9)

Origin

    

   Caucasian

38

(74.5)

27

(51.9)

   Non Caucasian

13

(25,5)

25

(48.1)

Age at disease onset (years)

    

   Range

1–12

-

   Mean ± SD

5.6 ± 3.2

-

   Median

5.8

-

Current age (years)

    

   Medium ± DP

11.3 ± 4.2

12.5 ± 3.5

   Median

12.3

13

Onset type JIA

    

   Oligoarticular

22 (43.1%)

-

   Polyarticular

17 (33.3%)

-

   Systemic

12 (23.6%)

-

Course type

    

   Oligoarticular

29 (56.9%)

-

   Polyarticular

22 (43.1%)

-

Active disease treatment

27 (52.9%)

  

   Methotrexate

32 (62.7%)

  

   NSAIDs

26 (51%)

  

   Chloroquine

10 (13.9%)

  

   Folic acid

32 (62.7%)

  

   Systemic steroids

4 (7.8%)

  
  1. JIA: juvenile idiopathic arthritis, NSAID s: nonsteroidal anti-inflammatory drugs